URL: http://www.leukemia-net.org/content/e58/e495/e5698/e504/index_eng.html

micronavigation ELN path item Leukemias path item CML path item Research path item Research  · 
Workpackage 4

Research & Publications

Created by: Hellenbrecht (ELIC) , generated 2006/03/14, last changed: 2007/10/30

application/pdf Molecular Biology (704KB)
Molecular Biology: Measuring and Reporting BCR-ABL Transcripts Level
Giuseppe Saglio
application/pdf Relative Risk (Sokal & Hasford) (1.6 MB)
Relative Risk (Sokal & Hasford): Relationship with Treatment Results
Michele Baccarani
application/pdf Imatinib in the Early Chronic Phase (1.6 MB)
Imatinib in the Early Chronic Phase
Richard Larson
application/pdf Diagnostic and Pre-treatment Work-up (675KB)
Diagnostic and Pre-treatment Work-up
François Guilhot
application/pdf Long-term benefit of imatinib (1.0 MB)
Long-term benefit of imatinib for patients newly diagnosed with CML in chronic phase: The 5-year update from IRIS study
Brian J. Druker
application/pdf Response-related Prognostic Factors (2.0 MB)
Response-related Prognostic Factors: The Cytogenetic Response
Michael Deininger
application/pdf Response-related Prognostic Factors (1.2 MB)
Response-related Prognostic Factors: The Molecular Response
Giuseppe Saglio
application/pdf Bcr-Abl Kinase Domain Mutations (897KB)
Bcr-Abl Kinase Domain Mutations
Martin Müller
application/pdf Response Definition, Evaluation and Monitoring (764KB)
Response Definition, Evaluation and Monitoring
Michele Baccarani
application/pdf Treatment Policy (613KB)
Treatment Policy
Rüdiger Hehlmann
application/pdf Venice Meeting Highlights: Key lessons (754KB)
Venice Meeting Highlights: Key lessons
Michele Baccarani, Rüdiger Hehlmann

Printing Date: 08.01.2009   ©  2004-2008 ELIC European Leukemia Information Center